Current status and future perspectives of platinum antitumor drugs

Yakugaku Zasshi

Volumn 128, Issue 3, 2008, Pages 307-316

  Chikuma, Masahiko ^a   Sato, Takaji ^a   Komeda, Seiji ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Anticancer agent; Apoptosis; Cisplatin; DNA; Drug resistance; Repair

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; NEDAPLATIN; OXALIPLATIN; PLATINUM DERIVATIVE; TRANSPLATIN;

ANTINEOPLASTIC ACTIVITY; CANCER RESISTANCE; CIS TRANS ISOMERISM; COMPLEX FORMATION; DNA DAMAGE; DNA REPAIR; DRUG DNA BINDING; DRUG MECHANISM; DRUG STRUCTURE; EXCISION REPAIR; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE TRANSPORT; REVIEW; TISSUE DISTRIBUTION; TUMOR CELL; UNSPECIFIED SIDE EFFECT;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; DNA DAMAGE; DNA REPAIR; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; HUMANS; ORGANOPLATINUM COMPOUNDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 40449139334     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.128.307     Document Type: Review

References (48)

1. Rosenberg B., Van Camp L., Krigas T., Nature (London), 205, 698-699 (1965).
2. Rosenberg B., Van Camp L., Trosko J. E., Mansour V. E., Nature (London), 222, 385-386 (1969).
3. Keppler B. K., "Metal Complexes in Cancer Chemotherapy," VCH, Weinheim, 1999.
4. Lippert B., "Cisplatin, Chemistry and Biochemistry of a Leading Anticancer Drug," Wiley-VCH, Weinheim, 1999.
5. Farrell N. P., "Use of Inorganic Chemistry in Medicine," Royal Society of Chemistry, Cambrige, 1999.
6. Barnes K. R., Lippard S. J., "Metal Ions in Biological Systems, Vol. 42," eds. by Sigel S., Sigel H., Marcel Dekker, N. Y., 2004, pp. 143-177.
7. Kidani Y., Inagaki K., Tsukagoshi S., Gann, 69, 863 (1978).
8. Martin R. B., "Cisplatin-Chemistry and Biochemistry of a Leading Anticancer Drug," ed. by Lippert B., Wiley-VCH, Weinheim, 1999, pp. 183-205.
9. Arpalahti A., "Perspectives on Bioinorganic Chemistry," eds. by Hay R. W., Dilworth J. R., Nolan K. B., JAI Press, New Haven, 1999.
10. Berg J. M., Lippard S. J., "Principles of Bioinorganic Chemsitry," University Science Books, Mill Valley, California, 1994.
11. Eastman A., Cancer Cells, 2, 275-280 (1990).
12. Kawai K., Kamatani N., Georges E., Ling V., J. Biol. Chem., 265, 13137-13142 (1990).
13. Chu G., J. Biol. Chem., 269, 787-790 (1994).
14. Hosking L. K., Whelan R. D. H., Shellard S. A., Bedford P., Hill B. T., Biochem. Pharmacol., 40, 1833-1842 (1990).
15. Ishikawa T., Ali-Osman F., J. Biol. Chem., 268, 20116-20125 (1993).
16. Kraker A., Schmidt J., Krezoski S., Peterring D.H., Biochem. Biophys. Res. Commun., 130, 786-792 (1985).
17. Naganuma A., Satoh M., Imura N., Toxicol. Lett., 24, 203-207 (1985).
18. Andrews P. A., Murphy M. P., Howell S. B., Cancer Chemother. Pharmacol., 19, 149-154 (1987).
19. Kelly S. L., Basu A., Teicher B., Hacker M., Harmer D., Lazo J., Science, 241, 1813-1815 (1988).
20. Naganuma A., Biomed. Res. Trace Elem., 11, 99-103 (2000).
21. Reedijk J., Chem. Rev., 99, 2499-2510 (1999).
22. Sancar A., Science, 266, 1954-1956 (1994).
23. Ciccarelli R., Solomon M., Varshavsky A., Lippard S. J., Biochemstry, 24, 7533-7540 (1985).
24. Jamieson E. R., Lippard S. J., Chem. Rev., 99, 2467-2498 (1999).
25. Pil P.M., Lippard S. J., Science, 256, 234-237 (1992).
26. Hughes E. N., Engelsberg B. N., Billings P. C., J. Biol. Chem., 267, 13520-13527 (1992).
27. Jones C. J., Wood R. D., Biochemistry, 32, 12096-12104 (1993).
28. Chu G., Chang E., Proc. Natl. Acad. Sci. U.S.A., 87, 3324-3327 (1990).
29. Zamble D. B., Lippard S. J., Trends Biochem. Sci., 20, 435-439 (1995).
30. Huang J.-C., Zamble D. B., Reardon J. T., Lippard S. J., Sancar A., Proc. Natl. Acad. Sci. U.S.A., 91, 10394-10398 (1994).
31. Zorba H., Keppler B. K., ChemBioChem, 6, 1157-1166 (2005).
32. Brabec V., Kasparkova J., Drug Resist. Updat., 8, 131-146 (2005).
33. Farrell N., Qu Y., Hacker M. P., J. Med. Chem., 33, 2179-2184 (1990).
34. Farrell N., Spinelli S., "Uses of Inorganic Chemistry in Medicine," ed. by Farrell N., Royal Society of Chemistry, Cambrige, 1999, pp. 124-134.
35. Farrell N., "Advances in DNA Sequence Specific Agents," Vol 2, eds. by Hurley L. H., Chaires J. B., JAI Press, New Haven, 1996, pp. 187-216.
36. Farell N., Qu Y., Bierbach U., Valsecchi M., Menta E., "Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drugs," ed. by Lippert B., Wiley-VCH, Weinheim, 1999, pp. 479-496.
37. Kasparkova J., Novakova O., Vrana O., Farrell N., Brabec V., Biochemistry, 38, 10997-11005 (1999).
38. Zaludova R., Zakovska A., Kasparkova J., Balcarova Z., Kleinwachter V., Vrana O., Farrell N., Brabec V., Eur. J. Biochem., 246, 508-517 (1997).
39. Kasparkova J., Farrell N., Brabec V., J. Biol. Chem., 275, 15789-15798 (2000).
40. Chikuma M., Hirai M., Komeda S., Kimura Y., Kumakura K., J. Inorg. Biochem., 67, 348 (1997).
41. Komeda S., Oishi H., Yamane H., Harikawa M., Chikuma M., J. Chem. Soc., Dalton Trans., 1999, 2959-2962.
42. Komeda S., Lutz M., Spek A. L., Chikuma M., Reedijk J., Inorg. Chem., 39, 4230-4236, (2000).
43. Komeda S., Chikuma M., "Metal Compounds in Cancer Chemotherapy," eds. by Perez J. M., Fuertes M. A., Alonso C., Research Signpost, Kelala, 2005, pp. 219-239.
44. Barnard C. F. J., Raynaud F. I., Kelland L. R., " Metallopharmaceuticals I," eds. by Clarke M. J., Sadler P. J., Springer-Verlag, Berlin, 1999, pp. 45-71.
45. Sternberg C. N., Whelan P., Hetherington J., Paluchowska B., Slee P. H. Th. J., Vekemans K., Van Erps P., Theodore C., Koriakine O., Oliver T., Lebwohl D., Debois M., Zurlo A., Collette L., Oncology, 68 (1), 2-9 (2005).
46. Wheats N. J., Collins J. G., Coord. Chem. Rev., 241, 133-145 (2003).
47. Harris A. L.,Yang X., Hegmans A., Povirk L., Ryan J. J., Kelland L., Farrell N. P., Inorg. Chem., 44, 9598-9600 (2005).
48. Okusaka T., Okada S., Nakanishi T., Fujiyama S., Kubo Y., Invest. New Drugs, 22, 169-176 (2004).